Supplemental material
Open access
3,662
Views
18
CrossRef citations to date
0
Altmetric
Research Paper
Design, synthesis, in vitro and in vivo evaluation of benzylpiperidine-linked 1,3-dimethylbenzimidazolinones as cholinesterase inhibitors against Alzheimer’s disease
Jun Moa School of Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of ChinaView further author information
, Tingkai Chenb Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing, People’s Republic of ChinaView further author information
, Hongyu Yanga School of Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of ChinaView further author information
, Yan Guoc School of pharmacy, Yantai University, Yantai, People’s Republic of ChinaView further author information
, Qi Lia School of Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of ChinaView further author information
, Yuting Qiaoa School of Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of ChinaView further author information
, Hongzhi Lina School of Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of ChinaView further author information
, Feng Fengb Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing, People’s Republic of China;d Jiangsu Food and Pharmaceutical Science College, Huaian, People’s Republic of ChinaView further author information
, Wenyuan Liua School of Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of ChinaView further author information
, Yao Chene School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
, View further author information
Zongliang Liub Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
& View further author information
Haopeng Suna School of Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of China;d Jiangsu Food and Pharmaceutical Science College, Huaian, People’s Republic of ChinaCorrespondence[email protected]
View further author information
show allView further author information
Pages 330-343
|
Received 09 Sep 2019, Accepted 22 Nov 2019, Published online: 20 Dec 2019
Related Research Data
Tacrine derivatives and Alzheimer's disease.
Source:
Bentham Science Publishers Ltd.
A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) Inhibitors.
Source:
American Chemical Society (ACS)
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core
Source:
Elsevier BV
Synthesis and activity towards Alzheimer's disease in vitro: Tacrine, phenolic acid and ligustrazine hybrids
Source:
Elsevier BV
A review on Alzheimer's disease pathophysiology and its management: an update
Source:
Springer Science and Business Media LLC
Therapies for Prevention and Treatment of Alzheimer’s Disease
Source:
Hindawi Limited
Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine
Source:
Elsevier BV
Discovery of new acetylcholinesterase and butyrylcholinesterase inhibitors through structure-based virtual screening
Source:
Royal Society of Chemistry (RSC)
Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-based compounds with potential activity as cholinesterase inhibitors and anti-Alzheimer's agents.
Source:
Elsevier BV
A Century of Alzheimer's Disease
Source:
American Association for the Advancement of Science (AAAS)
Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Source:
Elsevier BV
Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Source:
Taylor & Francis
Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.
Source:
Elsevier BV
Synthesis and bioevaluation of pyrazole-benzimidazolone hybrids as novel human 4-Hydroxyphenylpyruvate dioxygenase inhibitors.
Source:
Elsevier BV
Investigational drugs in Alzheimer's disease: current progress.
Source:
Informa UK Limited
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.